These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35384259)

  • 1. An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.
    Pehrsson M; Manon-Jensen T; Sun S; Villesen IF; Castañé H; Joven J; Patel K; Goodman Z; Nielsen MJ; Bay-Jensen AC; Leeming DJ; Mortensen JH; Karsdal MA
    Liver Int; 2022 Jul; 42(7):1605-1617. PubMed ID: 35384259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.
    Karsdal MA; Hjuler ST; Luo Y; Rasmussen DGK; Nielsen MJ; Holm Nielsen S; Leeming DJ; Goodman Z; Arch RH; Patel K; Schuppan D
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G25-G31. PubMed ID: 30160980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix remodeling proteins as biomarkers for clinical assessment and treatment outcomes in eosinophilic esophagitis.
    Pehrsson M; de Rooij WE; Bay-Jensen AC; Karsdal MA; Mortensen JH; Bredenoord AJ
    BMC Gastroenterol; 2023 Oct; 23(1):357. PubMed ID: 37845632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathy.
    Genovese F; Boor P; Papasotiriou M; Leeming DJ; Karsdal MA; Floege J
    Nephrol Dial Transplant; 2016 Mar; 31(3):472-9. PubMed ID: 26311218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRO-C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD.
    Cohen CC; Castillo-Leon E; Farris AB; Caltharp SA; Cleeton RL; Sinclair EM; Shevell DE; Karsdal MA; Nielsen MJF; Leeming DJ; Vos MB
    Hepatol Commun; 2021 Nov; 5(11):1860-1872. PubMed ID: 34558828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART.
    Dold L; Nielsen MJ; Praktiknjo M; Schwarze-Zander C; Boesecke C; Schierwagen R; Mohr R; Wasmuth JC; Jansen C; Bischoff J; Rockstroh JK; Karsdal MA; Spengler U; Trebicka J; Leeming DJ
    PLoS One; 2019; 14(7):e0219526. PubMed ID: 31295293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
    Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay.
    Veidal SS; Karsdal MA; Vassiliadis E; Nawrocki A; Larsen MR; Nguyen QH; Hägglund P; Luo Y; Zheng Q; Vainer B; Leeming DJ
    PLoS One; 2011; 6(9):e24753. PubMed ID: 21935455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.
    Nielsen MJ; Veidal SS; Karsdal MA; Ørsnes-Leeming DJ; Vainer B; Gardner SD; Hamatake R; Goodman ZD; Schuppan D; Patel K
    Liver Int; 2015 Feb; 35(2):429-37. PubMed ID: 25308921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen biology and non-invasive biomarkers of liver fibrosis.
    Karsdal MA; Daniels SJ; Holm Nielsen S; Bager C; Rasmussen DGK; Loomba R; Surabattula R; Villesen IF; Luo Y; Shevell D; Gudmann NS; Nielsen MJ; George J; Christian R; Leeming DJ; Schuppan D
    Liver Int; 2020 Apr; 40(4):736-750. PubMed ID: 31997561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis.
    Luo Y; Oseini A; Gagnon R; Charles ED; Sidik K; Vincent R; Collen R; Idowu M; Contos MJ; Mirshahi F; Daita K; Asgharpour A; Siddiqui MS; Jarai G; Rosen G; Christian R; Sanyal AJ
    Sci Rep; 2018 Aug; 8(1):12414. PubMed ID: 30120271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study.
    Dobrota R; Jordan S; Juhl P; Maurer B; Wildi L; Bay-Jensen AC; Karsdal MA; Herrick AL; Distler JHW; Allanore Y; Hoffmann-Vold AM; Siebuhr AS; Distler O
    Lancet Rheumatol; 2021 Mar; 3(3):e175-e184. PubMed ID: 38279380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.
    Leeming DJ; Karsdal MA; Byrjalsen I; Bendtsen F; Trebicka J; Nielsen MJ; Christiansen C; Møller S; Krag A
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1086-96. PubMed ID: 24099470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-invasive biomarker of type III collagen degradation reflects ischaemia reperfusion injury in rats.
    Rasmussen DGK; Nielsen PM; Kasab-Oglo ÖY; Nielsen SH; Kierulf-Lassen C; Karsdal MA; Genovese F; Nørregaard R
    Nephrol Dial Transplant; 2019 Aug; 34(8):1301-1309. PubMed ID: 30535162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats.
    Schierwagen R; Leeming DJ; Klein S; Granzow M; Nielsen MJ; Sauerbruch T; Krag A; Karsdal MA; Trebicka J
    Front Physiol; 2013; 4():195. PubMed ID: 23908632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver.
    Sojoodi M; Erstad DJ; Barrett SC; Salloum S; Zhu S; Qian T; Colon S; Gale EM; Jordan VC; Wang Y; Li S; Ataeinia B; Jalilifiroozinezhad S; Lanuti M; Zukerberg L; Caravan P; Hoshida Y; Chung RT; Bhave G; Lauer GM; Fuchs BC; Tanabe KK
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1483-1509. PubMed ID: 35093588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery.
    Bel Lassen P; Nori N; Bedossa P; Genser L; Aron-Wisnewsky J; Poitou C; Surabattula R; Juul Nielsen M; Asser Karsdal M; Julie Leeming D; Schuppan D; Clément K
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1356-e1366. PubMed ID: 34905051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters.
    Nielsen MJ; Nedergaard AF; Sun S; Veidal SS; Larsen L; Zheng Q; Suetta C; Henriksen K; Christiansen C; Karsdal MA; Leeming DJ
    Am J Transl Res; 2013; 5(3):303-15. PubMed ID: 23634241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen.
    Barascuk N; Veidal SS; Larsen L; Larsen DV; Larsen MR; Wang J; Zheng Q; Xing R; Cao Y; Rasmussen LM; Karsdal MA
    Clin Biochem; 2010 Jul; 43(10-11):899-904. PubMed ID: 20380828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis.
    Veidal SS; Vassiliadis E; Barascuk N; Zhang C; Segovia-Silvestre T; Klickstein L; Larsen MR; Qvist P; Christiansen C; Vainer B; Karsdal MA
    Liver Int; 2010 Oct; 30(9):1293-304. PubMed ID: 20666994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.